Tuberous sclerosis - Globe Thesis

Keyword [Tuberous sclerosis] Result: 41 - 60 \| Page: 3 of 5
41.	Efficacy And Safety Of Ketogenic Diet In Tuberous Sclerosis Complex With Epilepsy
42.	Regulation Of PERK-eIF2? Signaling By Tuberous Sclerosis Complex-1 Controls Homeostasis And Survival Of Mvelinating Oligodendrocytes
43.	Studies On The Function And Mechanism Of MTORC1-mediated Downregulation Of COX2 In Tuberous Sclerosis Complex
44.	Explore The Roles Of Gene Mutations In Malformations Of Cortical Development By Using High-throughput Sequencing
45.	Effects Of Chronic Rapamycin Treatment On Plasma Lipids And Fatty Acid Oxidation In Children With Tuberous Sclerosis Complex
46.	Tuberous Sclerosis Complex With Renal Angiomyolipomas:Cases Report And Literature Review
47.	Development Of Targeted Therapy For Tuberous Sclerosis Complex
48.	Clinical Characteristics And Pathogenic Mutations Of A Family Of Tuberous Sclerosis
49.	TSC1,TSC2 Gene Mutation Analysis And Prenatal Diagnosis Of Tuberous Sclerosis Complex
50.	Clinical Study On Vaccination In Infantile Spams And Tuberous Sclerosis Patients
51.	Investigation Of Physical Development Status Of Children With Tuberous Sclerosis Before And After The Treatment Of Rapamycin And Its Efficiency And Safety
52.	Magnetic Resonance Imaging Of Tuberous Sclerosis Complex And Focal Cortex Dysplasia With Epilepsy At Seven Tesla
53.	Mechanism Of Action Of TSC1 Of Dendritic Cells On Antigen-specific Initial T Cell Activation And Proliferation
54.	The Analysis Of Efficacy,Safety Of MTOR Inhibitor Sirolimus For The Treatment Of Epilepsy In Pediatric Patients With Tuberous Sclerosis(TSC)
55.	Mutational Analyses Of The TSC1 And TSC2 Genes In Cases Of Tuberous Sclerosis Complex
56.	Salicylic Acid Activates AMPK/TSC2 To Down Regulate MTOR's Growth Promotion Effect In Human Ovarian Cancer Cells
57.	Preliminary Identification Of Causative Gene For Tuberous Sclerosis Complex
58.	Mutation Analysis Of TSC1 And TSC2 Gene In Patients With Tuberous Sclerosis Complex
59.	Study Of Rapamycin Target Protein MTOR In The Treatment Of TSC-RAML
60.	Gankyrin Promotes The Initiation And Development Of Colorectal Cancer By Activating MTORC1
<<First <Prev Next> Last>> Jump to